Bilal Arif - 06 Oct 2025 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol
KALV
Transactions as of
06 Oct 2025
Transactions value $
$0
Form type
3
Filing time
08 Oct 2025, 18:58:37 UTC
Previous filing
06 Aug 2025
Next filing
08 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Arif Bilal Chief Operations Officer C/O KALVISTA PHARMACEUTICALS, INC., 200 CROSSING BOULEVARD, FRAMINGHAM /s/ Benjamin L. Palleiko, Attorney-in-Fact 08 Oct 2025 0001959750

No securities are beneficially owned.